About Us
Women first. Safety Focused. Science Driven.
Our commitment to rigorous science, evidence-based design, and women-first innovation is central to our mission to deliver safer, more durable, and more trusted pelvic health solutions that elevate the standard of care for women worldwide.
Mission Statement
To advance women’s pelvic health through next-generation biomaterials engineered to integrate with the body and perform over time.
Vision Statement
To redefine implantable care by replacing legacy materials with biocompatible, tissue-responsive solutions that clinicians trust and patients choose.
Leadership Team
Matthew Kemp
Chief Executive Officer
Matt is a proven healthcare executive with over 25 years of leadership experience across the biotech, pharmaceutical, and MedTech sectors. He has built a career driving innovation, commercialization, and operational execution—developing and scaling go-to-market strategies for breakthrough therapies and medical technologies across global markets.
Leslie Wise
Chief Operating Officer
Leslie has built a remarkable career characterized by innovation, leadership, and an unwavering commitment to advancing healthcare technologies. Through a unique blend of strategic insight and operational expertise, Leslie has consistently driven transformative results in the MedTech and life sciences sectors.
Christopher Chapple, BSc, MBBS, MD
Co-Inventor, Senior Medical Advisor
Professor Christopher Chapple is an internationally recognized authority in functional urology and lower urinary tract reconstruction, with more than four decades of academic, clinical, and regulatory leadership. Professor Chapple brings deep scientific expertise, clinical insight, and international standing to the company’s innovation.
Sheila MacNeil, Bsc, PhD
Co-Inventor, Senior Medical Advisor
She brings more than 20 years of innovative, translational research to the team, delivering products for burn patients and patients with scarring of the cornea culminating in the last 8 years developing Plielle. She has published more than 600 papers, and leads a team that has delivered new insights into the problems which develop with polystyrene mesh used in the pelvic floor. Based on this understanding, she developed and critically evaluated a new alternative material—Plielle—based on electrospinning an FDA approved polyurethane, which shows superior properties to polystyrene in terms of flexibility, resilience, and biocompatabilty.
